The current evidence regarding covid‐19 and pregnancy: Where are we now and where should we head to next?

Abstract

Despite the volume of publications dedicated to unraveling the biological characteristics and clinical manifestations of SARS‐CoV‐2, available data on pregnant patients are limited. In the current review of literature, we present an overview on the developmental course, complications, and adverse effects of COVID‐19 on pregnancy. A comprehensive review of the literature was per-formed in PubMed/Medline, Embase, and Cochrane Central databases up to June 2021. This article collectively presents what has been so far reported on the identified critical aspects, namely complications during pregnancy, delivery challenges, neonatal health care, potential routes of viral transmission, including vertical transmission or breastfeeding, along with the risks involved in the vaccination strategy during pregnancy. Despite the fact that we are still largely navigating un-charted territory, the observed publication explosion in the field is unprecedented. The overwhelm-ing need for data is undoubtable, and this serves as the driver for the plethora of publications wit-nessed. Nonetheless, the quality of data sourced is variable. In the midst of the frenzy for reporting on SARS‐CoV‐2 data, monitoring this informational overload is where we should head to next, con-sidering that poor quality research may in fact hamper our attempts to prevail against this unpar-alleled pandemic outbreak. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.